Fluvoxamine PCD Pharma Franchise Company
Cafoli Lifecare is a trusted Fluvoxamine PCD pharma franchise company offering 4 WHO-GMP certified formulations available in Tablets. We provide monopoly-based distribution rights to pharma entrepreneurs and distributors across India, backed by DCGI-approved quality and a reliable supply chain.
What is Fluvoxamine?
Fluvoxamine is a selective serotonin reuptake inhibitor (SSRI) that increases serotonin activity in the brain to help regulate mood and obsessive thoughts. It is a prescription-only medicine and should be used only under the supervision of a psychiatrist or physician. Read the compound profile on PubChem.
Available Fluvoxamine Formulations
Cafoli Lifecare offers 4 Fluvoxamine formulations for franchise partners. Available forms: Tablets. Every batch is manufactured at WHO-GMP certified facilities and supplied with full regulatory documentation. Pricing is shared on request.
Therapeutic Applications
Fluvoxamine is used to treat obsessive-compulsive disorder and depression. It is prescribed mainly by psychiatrists and general physicians.
Why Fluvoxamine is a High-Potential Molecule for Distributors
With obsessive-compulsive disorder and depression requiring months of continuous therapy, Fluvoxamine offers strong repeat-prescription value in the fast-expanding mental-health segment.
Why Choose Cafoli Lifecare
Cafoli Lifecare offers district-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved products, attractive promotional inputs and dedicated marketing support to a growing network of 1000+ franchise partners across India. Our focus on quality and on-time supply makes us a preferred Fluvoxamine franchise partner.
References
- PubChem: Fluvoxamine
- PubMed research on Fluvoxamine
Our formulations of Fluvoxamine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: